自身免疫性肝炎并肝硬化食管静脉曲张破裂出血硬化剂治疗的临床分析

Clinical analysis of sclerotherapy in treatment of esophageal variceal bleeding patients with autoimmune hepatitis and liver cirrhosis

目的分析自身免疫性肝炎肝硬化食管静脉曲张破裂出血硬化剂治疗的疗效。方法收集福建医科大学附属漳州市医院2012至2014年自身免疫性肝炎肝硬化失代偿期合并食管静脉曲张破裂出血患者4例,予内镜下硬化剂治疗。结果 4例患者均再发出血,2例3天内再出血,1例1周后再出血,1例1个月后再出血。结论自身免疫性肝炎肝硬化食管静脉曲张破裂出血硬化剂治疗效果较差。

Objective To analyze the efficacy of sclerotherapy in treatment of esophageal variceal bleeding patients with autoimmune hepatitis and liver cirrhosis. Methods Four patients of autoimmune hepatitis and decompensated liver cirrhosis complicated with esophageal varices bleeding in Zhangzhou Municipal Hospital Affiliated to Fujian Medical University from 2012 to 2014 were analyzed. All the patients were given endoscopic sclerotherapy. Results Rebleeding occurred in all patients, two of whom occured within three days, one was in one week later and another in one months later. Conclusion Sclerotherapy has poor effects in treatment of sophageal variceal bleeding patients with autoimmune hepatitis and liver cirrhosis.